Semaphorin 3F: A Novel Biologic Treatment for Oral Squamous Cell Carcinoma

Asma Almazyad; Yao Gao; Shokoufeh Shahrabi-Farahani; Lufei Sui; Allison Gartung; Randy Watnick; Dipak Panigrahy; Rosalyn M. Adam; Diane R. Bielenberg

doi:10.1096/fasebj.2020.34.s1.02668

Back

Semaphorin 3F: A Novel Biologic Treatment for Oral Squamous Cell Carcinoma

Journal article

Peer reviewed

Semaphorin 3F: A Novel Biologic Treatment for Oral Squamous Cell Carcinoma

Asma Almazyad, Yao Gao, Shokoufeh Shahrabi-Farahani, Lufei Sui, Allison Gartung, Randy Watnick, Dipak Panigrahy, Rosalyn M. Adam and Diane R. Bielenberg

The FASEB journal, Vol.34(S1), pp.1-1

04/2020

DOI: https://doi.org/10.1096/fasebj.2020.34.s1.02668

Metrics

1 Record Views

Details

Title: Semaphorin 3F: A Novel Biologic Treatment for Oral Squamous Cell Carcinoma
Creators - without role: Asma Almazyad - Boston Children's Hospital
Yao Gao - Boston Children's Museum
Shokoufeh Shahrabi-Farahani - University of Tennessee at Knoxville
Lufei Sui - Boston Children's Museum
Allison Gartung - Hadassah Medical Center
Randy Watnick - Boston Children's Museum
Dipak Panigrahy - Hadassah Medical Center
Rosalyn M. Adam - Boston Children's Museum
Diane R. Bielenberg - Boston Children's Museum
Publication Details: The FASEB journal, Vol.34(S1), pp.1-1
Identifiers: 9921652908331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article